It's one of the most common causes of vision loss, and one of the easiest to overlook. Glaucoma symptoms develop so gradually ...

The MarketWatch News Department was not involved in the creation of this content. Program ensures continued access to treatment for patients enrolled in the Federal Employee & Retirees Health Plan ...

The MarketWatch News Department was not involved in the creation of this content. Data to be shared during an ObesityWeek press conference includes four of seven data presentations supporting CONTRAVE ...

The use of alpha-blockers for benign prostatic hyperplasia is tied to an increased risk of developing acute angle-closure glaucoma, a study finds.

DelveInsight's“ Open-angle Glaucoma Pipeline Insight 2025” report provides comprehensive insights about 18+ companies and 20+ pipeline drugs in the Open-angle Glaucoma pipeline landscape. It covers ...

Machine learning models can predict postoperative hyperopic shift in patients with primary angle-closure glaucoma.

Their 'One That Got Away' Married Someone Else. This Was The Hardest Thing To Accept. What Amazon’s mass layoffs are really about Huge Brazilian raid on Rio gang leaves at least 60 people dead and 81 ...

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully integrated, commercial biotechnology ...

JAMES CITY COUNTY, Va. — Drivers traveling on I-64 east should expect an overnight closure this week as crews install a new overhead sign, according to the Virginia Department of Transportation (VDOT) ...

Johnson & Johnson (NYSE:JNJ) today announced the U.S. Food and Drug Administration (FDA) approved DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) as a single agent treatment for adult patients ...

Program ensures continued access to treatment for patients enrolled in the Federal Employee & Retirees Health Plan (FEP) BRENTWOOD, Tenn., Oct. 23, 2025 /PRNewswire/ -- Currax Pharmaceuticals LLC, a ...

Data to be shared during an ObesityWeek press conference includes four of seven data presentations supporting CONTRAVE and its utility in helping people lose weight BRENTWOOD, Tenn., Oct. 28, 2025 ...